Search clinical trials for: Symphony DR 2550 and REPLY DR cardiac pacemakers

Total 7 results

LivaNova

Completed

Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indication (ANSWER)

Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients.

Italy, France, Spain, United States, Germany, United Kingdom
LivaNova

Completed

Spontaneous Atrio Ventricular Conduction Preservation (SAVER)

Sinus Node Dysfunction | Bradycardia-Tachycardia Syndrome | Paroxysmal Atrioventricular Block

United Kingdom, France, Germany, Belgium, Italy
LivaNova

Completed

Evolution of the PR Interval in Patients Implanted With a Pacemaker Using the SafeR Mode (PRECISE)

Atrioventricular Block | Sinus Node Dysfunction

France
Biotronik, Inc.

Terminated

Investigational Device Exemption (IDE) Study for the Approval of Closed Loop Stimulation (CLS) and Cardiac Resyncronization Pacing Therapies (CRT) for the Treatment of Atrial Fibrillation (AF) With Ablate and Pace (AVAIL)

Atrial Fibrillation | Congestive Heart Failure

United States
ELA Medical, Inc.

Completed

Ovatio DR and VR Implantable Cardioverter Defibrillators Post-approval Study (Post-Ovatio)

Sudden Cardiac Death

United States
Biotronik SE & Co. KG

Completed

TD01 Master Study (Safety and Efficacy Study)

ICD/CRT-D Indication

Germany, Austria
Biotronik SE & Co. KG

Completed

ProMRI AFFIRM Study of the EVIA/ENTOVIS Pacemaker With Safio S Pacemaker Leads (ProMRIAFFIRM)

Cardiac Disease

Germany, Czech Republic, Switzerland, Austria, United Kingdom

3

Subscribe